Huapont Life Sciences Co., Ltd.
Simbolis: 002004.SZ
SHZ
4.42
CNYRinkos kaina šiandien
32.7334
P/E santykis
0.7053
PEG koeficientas
8.58B
MRK kapitalizacija
- 0.05%
DIV pajamingumas
Huapont Life Sciences Co., Ltd. (002004-SZ) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 18416.54 | 4413.1 | 4892.9 | 5416.6 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 2174.44 | 630.3 | 706.3 | 1030.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 12013.25 | 2844.7 | 3059.7 | 3587.9 | |||||||||||||||||||||||
balance-sheet.row.inventory | 10688.67 | 2674.6 | 2535.6 | 2402.3 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 5150.15 | 1454.9 | 1066 | 907.2 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 46268.61 | 11387.4 | 11554.2 | 12314.1 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 38610.88 | 10024.5 | 8917.6 | 8052.8 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 11376.06 | 2739.9 | 2948.1 | 3439.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 6781.25 | 1652.4 | 1759.3 | 1731 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 18157.31 | 4392.4 | 4707.4 | 5170.9 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 9562.98 | 2253.5 | 2234 | 1503.3 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 1649.71 | 434 | 337.1 | 266.2 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 8760.43 | 2235.6 | 2274.1 | 2737.1 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 76741.32 | 19340 | 18470.2 | 17730.4 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 123009.93 | 30727.4 | 30024.4 | 30044.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 9675.35 | 2702.9 | 2374.8 | 2439.3 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 24167.28 | 5693.8 | 6264 | 6294.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 916.31 | 177 | 313.2 | 226.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 10912.67 | 2932.1 | 1783.7 | 2273.2 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1144.41 | 271.2 | 278.2 | 258.1 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 430.25 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 149.59 | 29.7 | 2134.1 | 469 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 13263.79 | 3508.9 | 2362 | 2831.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 189.03 | 47.6 | 41.9 | 51.6 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 56250.38 | 14142.7 | 13473.6 | 14220.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 84.95 | 84.9 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 7919.68 | 1979.9 | 1979.9 | 1979.9 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9945.12 | 2336.8 | 2544.8 | 2646.9 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 12339.24 | -84.9 | 890.3 | 719.2 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 10549.87 | 5788.5 | 4777 | 4763.4 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 40838.85 | 10105.2 | 10192 | 10109.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 123009.93 | 30727.4 | 30024.4 | 30044.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 25920.71 | 6479.6 | 6358.8 | 5714.4 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 66759.56 | 16584.7 | 16550.8 | 15823.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 123009.93 | - | - | - | |||||||||||||||||||||||
Total Investments | 11737.43 | 2883.8 | 2940.3 | 2533.7 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 35079.95 | 8625.8 | 8047.7 | 8567.7 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 18837.85 | 4843 | 3861.1 | 4181.5 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 280.54 | 1126.7 | 925 | 895 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 696.35 | 800.2 | 747.9 | 696.3 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -68.6 | 11.4 | -25.5 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 49.5 | -11.4 | 13 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -800.57 | -162.1 | -843.9 | 294.8 | |||||||||||||||||||||
cash-flows.row.account-receivables | -587.98 | 59.6 | -1039.7 | -128.8 | |||||||||||||||||||||
cash-flows.row.inventory | -201.92 | -154.6 | -456.1 | 142.2 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 1.5 | 645.4 | 306.9 | |||||||||||||||||||||
cash-flows.row.other-working-capital | -10.67 | -68.6 | 6.4 | -25.5 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 1553.85 | 662.1 | 440.7 | 499.1 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1730.18 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1379.1 | -1131.2 | -1256.4 | -1231.2 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 16.29 | -15.8 | -40.1 | 29.8 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -8385.3 | -7141.8 | -7267.4 | -10125.4 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 7625.57 | 7908.8 | 7749.1 | 9612.7 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | -161.49 | -176.4 | 24.4 | -46.2 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2275.27 | -556.5 | -790.4 | -1760.3 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -6196.07 | -7897.8 | -10279 | -11984.1 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | -4.6 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 4.6 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -761.1 | -854.4 | -859.4 | -943.1 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 5333.16 | 7382 | 10934.7 | 12687.6 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 734.91 | -1370.3 | -203.8 | -239.6 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 18.38 | 7.3 | 11.1 | -30.1 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 191.84 | 488.4 | 286.5 | 342.8 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 12298.85 | 2991.3 | 2503 | 2216.5 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 12107.02 | 2503 | 2216.5 | 1873.7 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 1730.18 | 2407.9 | 1269.6 | 2372.7 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -1379.1 | -1131.2 | -1256.4 | -1231.2 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 351.08 | 1276.7 | 13.2 | 1141.6 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 11534.53 | 11594.6 | 13232.4 | 12359.2 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 7096.24 | 7059.5 | 7874.1 | 7605.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 4438.29 | 4535.1 | 5358.3 | 4753.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 412.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 432.26 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1317.3 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -30.25 | -34.1 | 921.7 | 784.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 3043.2 | 3032.2 | 3350 | 3130 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 10139.44 | 10091.7 | 11224.1 | 10735.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 86.54 | 85.2 | 88 | 80.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 345.8 | 343.7 | 434 | 461.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1317.3 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -30.25 | -34.1 | -1031.2 | -607.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -30.25 | -34.1 | 921.7 | 784.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -30.25 | -34.1 | -1031.2 | -607.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 345.8 | 343.7 | 434 | 461.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 671.4 | 891.2 | 800.2 | 747.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1510.64 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 839.23 | 926.5 | 2653.9 | 1893.9 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 808.99 | 892.4 | 1622.7 | 1286 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 212.47 | 215.5 | 496 | 361 | |||||||||||||||||||||||
income-statement-row.row.net-income | 280.54 | 302.1 | 1126.7 | 925 |
Dažnai užduodami klausimai
Kas yra Huapont Life Sciences Co., Ltd. (002004.SZ) bendras turtas?
Huapont Life Sciences Co., Ltd. (002004.SZ) bendras turtas yra 30727396560.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 5657008739.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.385.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.177.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.024.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.073.
Kas yra Huapont Life Sciences Co., Ltd. (002004.SZ) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 302122026.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 8625844451.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 3032172071.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 4112423354.000.